Genetically engineered hookworms can now secrete human therapeutic antibodies directly into their host's circulation, offering a potential single-dose, years-long drug delivery platform
Researchers have genetically engineered hookworms to produce human therapeutic antibodies within a host. These modified hookworms can secrete the antibodies directly into the host's bloodstream. This breakthrough offers a potential method for long-term drug delivery, possibly requiring only a single dose for years of effect. AI